Gene: Gfpt1 MGI:95698
Log in to followPhenotypes
The IMPC applies a panel of phenotyping screens to characterise single-gene knockout mice by comparison to wild types. Click on the different tabs to visualise significant phenotypes identified by the IMPC, as well as all data that was measured.
Phenotype | System | Allele | Zyg | Sex | Life Stage | P Value |
---|---|---|---|---|---|---|
increased circulating HDL cholesterol level | Gfpt1tm1b(EUCOMM)Wtsi | HET | Early adult | 8.38×10-05 | ||
persistence of hyaloid vascular system | Gfpt1tm1b(EUCOMM)Wtsi | HET | Early adult | 7.02×10-05 | ||
embryonic lethality prior to tooth bud stage | Gfpt1tm1b(EUCOMM)Wtsi | HOM | E12.5 | 0.00 | ||
preweaning lethality, complete penetrance | Gfpt1tm1b(EUCOMM)Wtsi | HOM | Early adult | 0.00 | ||
increased circulating cholesterol level | Gfpt1tm1b(EUCOMM)Wtsi | HET | Early adult | 8.38×10-06 |
An assay measuring the expression of lacZ shows the tissue where the gene is expressed.
Anatomy | Images | Zygosity | Mutant Expr |
---|---|---|---|
Adrenal gland | Wholemount images | heterozygote | 100% (2 of 2) |
Aorta | Wholemount images | heterozygote | 100% (2 of 2) |
Bone | Wholemount images | heterozygote | 100% (2 of 2) |
Brain | Wholemount images | heterozygote | 100% (2 of 2) |
Brainstem | Wholemount images | heterozygote | 100% (2 of 2) |
Cartilage tissue | Wholemount images | heterozygote | 100% (2 of 2) |
Cerebellum | Wholemount images | heterozygote | 100% (2 of 2) |
Cerebral cortex | Wholemount images | heterozygote | 100% (2 of 2) |
Esophagus | Wholemount images | heterozygote | 100% (2 of 2) |
Eye | Wholemount images | heterozygote | 100% (2 of 2) |
Gall bladder | Wholemount images | heterozygote | 100% (2 of 2) |
Heart | Wholemount images | heterozygote | 100% (2 of 2) |
Hippocampus | Wholemount images | heterozygote | 100% (2 of 2) |
Hypothalamus | Wholemount images | heterozygote | 100% (2 of 2) |
Kidney | Wholemount images | heterozygote | 100% (2 of 2) |
Large intestine | Wholemount images | heterozygote | 100% (2 of 2) |
Liver | Wholemount images | heterozygote | 100% (2 of 2) |
Lower urinary tract | Wholemount images | heterozygote | 100% (2 of 2) |
Lung | Wholemount images | heterozygote | 100% (2 of 2) |
Lymph node | Wholemount images | heterozygote | 100% (2 of 2) |
Mammary gland | Wholemount images | heterozygote | 50% (1 of 2) |
Olfactory lobe | Wholemount images | heterozygote | 100% (2 of 2) |
Oral epithelium | Wholemount images | heterozygote | 100% (2 of 2) |
Ovary | Wholemount images | heterozygote | 50% (1 of 2) |
Oviduct | Wholemount images | heterozygote | 50% (1 of 2) |
Pancreas | Wholemount images | heterozygote | 100% (2 of 2) |
Parathyroid gland | Wholemount images | heterozygote | 100% (2 of 2) |
Peripheral nervous system | Wholemount images | heterozygote | 100% (2 of 2) |
Peyer's patch | Wholemount images | heterozygote | 100% (2 of 2) |
Pituitary gland | Wholemount images | heterozygote | 100% (2 of 2) |
Prostate gland | Wholemount images | heterozygote | 50% (1 of 2) |
Skeletal muscle | Wholemount images | heterozygote | 100% (2 of 2) |
Skin | Wholemount images | heterozygote | 100% (2 of 2) |
Small intestine | Wholemount images | heterozygote | 100% (2 of 2) |
Spinal cord | Wholemount images | heterozygote | 100% (2 of 2) |
Spleen | Wholemount images | heterozygote | 100% (2 of 2) |
Stomach | Wholemount images | heterozygote | 100% (2 of 2) |
Striatum | Wholemount images | heterozygote | 100% (2 of 2) |
Testis | Wholemount images | heterozygote | 50% (1 of 2) |
Thymus | Wholemount images | heterozygote | 100% (2 of 2) |
Thyroid gland | Wholemount images | heterozygote | 100% (2 of 2) |
Trachea | Wholemount images | heterozygote | 100% (2 of 2) |
Uterus | Wholemount images | heterozygote | 50% (1 of 2) |
Vascular system | Wholemount images | heterozygote | 100% (2 of 2) |
Brown adipose tissue | N/A | heterozygote | 0.0% (0 of 2) |
White adipose tissue | N/A | heterozygote | 0.0% (0 of 2) |
An assay measuring the expression of lacZ shows the tissue where the gene is expressed.
Anatomy | Images | Zygosity | Mutant Expr |
---|---|---|---|
Brain | N/A | heterozygote | 100% (2 of 2) |
Ear | N/A | heterozygote | 50% (1 of 2) |
Embryo | N/A | heterozygote | 100% (2 of 2) |
Eye | N/A | heterozygote | 100% (2 of 2) |
Footplate | N/A | heterozygote | 100% (2 of 2) |
Forebrain | N/A | heterozygote | 100% (2 of 2) |
Forelimb | N/A | heterozygote | 100% (2 of 2) |
Handplate | N/A | heterozygote | 100% (2 of 2) |
Head | N/A | heterozygote | 100% (2 of 2) |
Heart | N/A | heterozygote | 50% (1 of 2) |
Hindbrain | N/A | heterozygote | 100% (2 of 2) |
Hindlimb | N/A | heterozygote | 100% (2 of 2) |
Liver | N/A | heterozygote | 50% (1 of 2) |
Lung | N/A | heterozygote | 50% (1 of 2) |
Mandibular process | N/A | heterozygote | 50% (1 of 2) |
Maxillary process | N/A | heterozygote | 50% (1 of 2) |
Midbrain | N/A | heterozygote | 100% (2 of 2) |
Oral cavity | N/A | heterozygote | 50% (1 of 2) |
Skin | N/A | heterozygote | 50% (1 of 2) |
Tail somite | N/A | heterozygote | 100% (2 of 2) |
Tail | N/A | heterozygote | 100% (2 of 2) |
Background staining occurs in wild type mice and embryos at an incidental rate.
Anatomy | Background staining in controls (WT) |
---|---|
adrenal gland | 0.7% (4 of 575) |
aorta | 0.0% |
bone | 0.0% |
brain | 0.87% (5 of 577) |
brainstem | 0.35% (2 of 579) |
brown adipose tissue | 0.0% |
cartilage tissue | 0.17% (1 of 579) |
cerebellum | 0.52% (3 of 581) |
cerebral cortex | 0.35% (2 of 574) |
esophagus | 1.73% (7 of 404) |
eye | 0.0% |
gall bladder | 0.0% |
heart | 0.35% (2 of 571) |
hippocampus | 0.34% (2 of 586) |
hypothalamus | 0.35% (2 of 577) |
kidney | 4.66% (27 of 580) |
large intestine | 5.15% (30 of 583) |
liver | 0.0% |
lower urinary tract | 0.17% (1 of 583) |
lung | 0.34% (2 of 588) |
lymph node | 0.17% (1 of 587) |
mammary gland | 0.0% |
olfactory lobe | 0.17% (1 of 579) |
oral epithelium | 0.0% |
ovary | 0.17% (1 of 576) |
oviduct | 0.0% |
pancreas | 0.87% (5 of 578) |
parathyroid gland | 0.18% (1 of 558) |
peripheral nervous system | 0.34% (2 of 580) |
peyers patch | 0.0% |
pituitary gland | 0.17% (1 of 576) |
prostate gland | 1.89% (11 of 583) |
skeletal muscle | 0.0% |
skin | 0.17% (1 of 577) |
small intestine | 5.34% (31 of 581) |
spinal cord | 0.52% (3 of 576) |
spleen | 0.52% (3 of 581) |
stomach | 3.61% (21 of 582) |
striatum | 0.52% (3 of 582) |
testis | 1.03% (6 of 584) |
thymus | 0.17% (1 of 582) |
thyroid gland | 3.1% (18 of 581) |
trachea | 0.34% (2 of 589) |
uterus | 0.35% (2 of 579) |
vascular system | 0.0% |
white adipose tissue | 0.0% |
Background staining occurs in wild type mice and embryos at an incidental rate.
Background staining occurs in wild type embryos at a measurable rate.
Anatomy | Background staining in controls(WT) |
---|---|
brain | 1.17% (6 of 511) |
ear | 0.2% (1 of 511) |
embryo | 0.39% (2 of 512) |
eye | 0.2% (1 of 511) |
footplate | 0.2% (1 of 511) |
forebrain | 0.2% (1 of 511) |
forelimb | 0.2% (1 of 511) |
handplate | 0.2% (1 of 511) |
head | 0.98% (5 of 511) |
heart | 0.2% (1 of 511) |
hindbrain | 1.17% (6 of 511) |
hindlimb | 0.2% (1 of 511) |
liver | 0.2% (1 of 506) |
lung | 0.2% (1 of 506) |
mandibular process | 0.2% (1 of 511) |
maxillary process | 0.2% (1 of 511) |
midbrain | 0.2% (1 of 511) |
oral cavity | 0.2% (1 of 506) |
skin | 0.2% (1 of 511) |
tail | 0.2% (1 of 511) |
tail somite group | 0.2% (1 of 511) |
Human diseases caused by Gfpt1 mutations
The analysis uses data from IMPC, along with published data on other mouse mutants, in comparison to human disease reports in OMIM, Orphanet, and DECIPHER.
Phenotype comparisons summarize the similarity of mouse phenotypes with human disease phenotypes.
The table below shows human diseases associated to Gfpt1 by orthology or direct annotation.
Disease | Similarity of phenotypes |
Matching phenotypes | Source |
---|---|---|---|
Myasthenic Syndrome, Congenital, 12 | Mildly elevated creatine kinase | OMIM:610542 | |
Congenital Myasthenic Syndromes With Glycosylation Defect | Elevated circulating creatine kinase concentration | ORPHA:353327 |
The table below shows human diseases predicted to be associated to Gfpt1 by phenotypic similarity.
IMPC related publications
The table below lists publications which used either products generated by the IMPC or data produced by the phenotyping efforts of the IMPC. These publications have also been associated to Gfpt1.
There are 2 publications which use IMPC produced mice or data.
Title | Journal | IMPC Allele | PubMed ID |
---|---|---|---|
Dietary glucosamine overcomes the defects in αβ-T cell ontogeny caused by the loss of de novo hexosamine biosynthesis. | Nature communications (December 2022) | Gfpt1tm1a(EUCOMM)Wtsi | PMC9715696 |
GFPT1 deficiency in muscle leads to myasthenia and myopathy in mice. | Human molecular genetics (September 2018) | Gfpt1tm1a(EUCOMM)Wtsi | PMC6121184 |
Order Mouse and ES Cells
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
MGI Allele | Allele Type | Produced |
---|---|---|
Gfpt1tm1e(EUCOMM)Wtsi | Targeted, non-conditional allele | ES Cells |
Gfpt1tm1a(EUCOMM)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | Mice, Targeting vectors, ES Cells |
Gfpt1tm1b(EUCOMM)Wtsi | Reporter-tagged deletion allele (with selection cassette) | Mice |
Gfpt1tm1c(EUCOMM)Wtsi | Wild type floxed exon (post-Flp) | Mice |
The IMPC Newsletter
Get highlights of the most important data releases, news and events, delivered straight to your email inbox
Subscribe to newsletter